Drag a card by its title · ⚙ to size, swap or remove

The company

Impact BioMedical, Inc.

IBO · NYSE American

Health CareBiotechnologyNot moving yet

IBO stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 52.8% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 4
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $119K
Officials’ trades on record: 0
Institutions holding: 19 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months6

Buyers · sellers0 · 3

Who	Did	Shares	Traded
Dss, Inc.10% owner	sold	156at $7.06	24 Sep 2026filed 24 Sep 2026
Dss, Inc.10% owner	sold	27at $6.95	23 Sep 2026filed 24 Sep 2026
Dss, Inc.10% owner	sold	723at $0.55	22 Sep 2026filed 24 Sep 2026
Todd D. MackoChief Financial Officer	sold	43,400at $0.5615	27 Mar 2026filed 30 Mar 2026
Todd D. MackoChief Financial Officer	sold	1,600at $0.6008	25 Mar 2026filed 30 Mar 2026
Jason GradyDirector	sold	50,000at $0.6501	23 Mar 2026filed 25 Mar 2026
Dss, Inc.10% owner	sold	45,400at $0.5403	27 May 2025filed 6 Jan 2026
Dss, Inc.10% owner	sold	115,600at $0.5491	22 May 2025filed 6 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders19+0 on the quarter

New · exited2 · 1

Reported value$1.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	1,185,163$546K	-7,762−0.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	808,689$372K	+100,521+14.2%
STATE STREET CORPunchanged · filed 7 Aug 2026	607,897$280K	00.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	589,428$271K	+4,230+0.7%
BlackRock, Inc.unchanged · filed 7 Aug 2026	259,946$120K	00.0%
NORTHERN TRUST CORPreduced · filed 13 Aug 2026	235,475$108K	-8,468−3.5%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026	49,567$23K	+49,567
Vanguard Global Advisers, LLCunchanged · filed 13 Aug 2026	32,201$15K	00.0%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026	24,528$11K	+24,528
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026	17,191$7,908	-20,236−54.1%